News

Leucine Rich Bio with Micro Health Labs to launch BugSpeaks in Qatar, pioneering gut microbiome test globally: Our Bureau, Bengaluru Friday, May 9, 2025, 15:45 Hrs [IST] Leucine R ...
Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Ginkgo Bioworks, which is building the leading platform for ...
HLS Therapeutics partners with Esperion Therapeutics to commercialize Nexletol and Nexlizet in Canada: Toronto Friday, May 9, 2025, 14:00 Hrs [IST] HLS Therapeutics Inc. (HLS), a ...
CASI Pharma receives notice from Nasdaq regarding minimum market value requirement: Beijing, China Friday, May 9, 2025, 13:30 Hrs [IST] CASI Pharmaceuticals, Inc, a biopharmaceuti ...
Agilent inaugurates India Solution Centre to accelerate innovation and expand the frontiers of science: Our Bureau, Mumbai ...
India’s No. 1 pharma company by revenues and prescriptions has launched its corporate brand campaign that highlights its ...
FY25 revenue at Rs. 4,454 crore up by 15%, net profit at Rs 344 crore: Our Bureau, Bengaluru Friday, May 9, 2025, 12:30 Hrs [IST] Biocon in its consolidated financial re ...
Govt of Telangana appoints Shahnawaz Qasim, director general of the drug control administration ...
Major mass photometry milestone achieved by Refeyn with installation of 500 system globally: Oxford, UK Friday, May 9, 2025, 13:00 Hrs [IST] Refeyn, the company behind pioneering ...
GeneFab, RegCell partner to advance autoimmune cell therapy into US clinical trials: Alameda, California Friday, May 9, 2025, 12:00 Hrs [IST] GeneFab, a next-generation cell and g ...
A non-invasive breast cancer screening test, Revealia Breast offers glimpse to future of early cancer detection: Miami, Florida Friday, May 9, 2025, 11:00 Hrs [IST] Enterprises, I ...
More patients in the linerixibat group had clinically meaningful itch improvement (WI-NRS =3-point reduction) with 56% versus 43% in the placebo group at week 24 (treatment difference 13% [95% CI ...